Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Korro Bio (KRRO) Non Operating Income (2021 - 2025)

Korro Bio (KRRO) has disclosed Non Operating Income for 5 consecutive years, with $1.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non Operating Income fell 48.51% year-over-year to $1.2 million, compared with a TTM value of $6.2 million through Sep 2025, down 21.42%, and an annual FY2024 reading of $8.5 million, up 149.93% over the prior year.
  • Non Operating Income was $1.2 million for Q3 2025 at Korro Bio, down from $1.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.3 million in Q2 2024 and bottomed at -$227000.0 in Q2 2022.
  • Average Non Operating Income over 5 years is $1.1 million, with a median of $980500.0 recorded in 2023.
  • The sharpest move saw Non Operating Income surged 1676.92% in 2022, then crashed 48.51% in 2025.
  • Year by year, Non Operating Income stood at -$39000.0 in 2021, then soared by 1676.92% to $615000.0 in 2022, then soared by 118.86% to $1.3 million in 2023, then skyrocketed by 44.43% to $1.9 million in 2024, then crashed by 39.51% to $1.2 million in 2025.
  • Business Quant data shows Non Operating Income for KRRO at $1.2 million in Q3 2025, $1.4 million in Q2 2025, and $1.6 million in Q1 2025.